Milestone Scientific wants to bring subcutaneous injections into the 21st century

As a dentist, Mark Hochman gave countless injections to his patients and watched as many of them would cringe from pain. Frustrated with a technology that he said hasn’t improved in decades, he decided to take a different approach to the common method of drug delivery.

“A team of us got together to evaluate whether we could change the way that subcutaneous drug delivery was being performed in this country and around the world,” Hochman told Drug Delivery Business News. “We realized that as one of the many routes of administration for drug delivery, it was being practiced on a device that was over 160 years old, which is basically the conventional syringe.”

Twenty years later, he now serves as director of clinical affairs and R&D at Milestone Scientific (NYSE:MLSS), working to bring the company’s CompuFlo system to patients and healthcare providers.

Get the full story at our sister site, Drug Delivery Business News.

The post Milestone Scientific wants to bring subcutaneous injections into the 21st century appeared first on MassDevice.

from MassDevice http://ift.tt/2vk0hVW